SIGN UP
LOG IN
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga·04/02/2025 17:06:16
Listen to the news
Gainers
- Allakos (NASDAQ:ALLK) stock rose 48.2% to $0.32 during Wednesday's regular session. The company's market cap stands at $29.0 million.
- Alaunos Therapeutics (NASDAQ:TCRT) shares moved upwards by 43.52% to $3.1. The market value of their outstanding shares is at $4.9 million.
- Genprex (NASDAQ:GNPX) shares rose 43.37% to $0.33. The company's market cap stands at $2.8 million.
- Scilex Holding (NASDAQ:SCLX) shares rose 33.97% to $0.32. The company's market cap stands at $58.3 million.
- Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 30.52% to $2.71. The market value of their outstanding shares is at $7.3 million.
- Alumis (NASDAQ:ALMS) shares increased by 29.62% to $9.38. The market value of their outstanding shares is at $510.6 million.
Losers
- Reshape Lifesciences (NASDAQ:RSLS) stock fell 67.3% to $0.52 during Wednesday's regular session. The company's market cap stands at $1.7 million.
- Syra Health (NASDAQ:SYRA) stock declined by 35.72% to $0.17. The market value of their outstanding shares is at $2.0 million.
- Impact BioMedical (AMEX:IBO) shares declined by 28.42% to $0.59. The market value of their outstanding shares is at $6.7 million.
- Edgewise Therapeutics (NASDAQ:EWTX) shares decreased by 24.05% to $15.29. The company's market cap stands at $1.4 billion.
- NeOnc Technologies (NASDAQ:NTHI) stock fell 23.89% to $8.57. The market value of their outstanding shares is at $193.3 million.
- Processa Pharmaceuticals (NASDAQ:PCSA) stock declined by 22.31% to $0.32. The market value of their outstanding shares is at $1.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.